Security
PMGC Holdings Inc. Common Stock · ELAB
ELABNASDAQCommon stockCurrentCIK 1840563Updated Nov 6, 2026
Name history
Elevai Labs Inc. · through Nov 27, 2024Reactive Medical Labs Inc. · through Oct 14, 2021
ELAB price & chart
Loading TradingView…
NASDAQ:ELAB on TradingView ↗About the company
We are dedicated to enhancing our portfolio through the acquisition of operating companies and innovative biotechnology assets that align with our growth mission, while actively pursuing the acquisition of operating companies.
In the news
These Companies Just Dropped Major Growth Catalysts ↗
Recent filings
10-Q filing
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Regulation FD Disclosure
Items 7.01, 9.01
Regulation FD Disclosure
Items 7.01, 9.01
Show 5 more recent filings
Entry into a Material Definitive Agreement · Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD Disclosure
Items 1.01, 3.03, 5.03, 7.01, 9.01
Entry into a Material Definitive Agreement · Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD Disclosure · Other Events
Items 1.01, 3.03, 5.03, 7.01, 8.01, 9.01
10-Q filing
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 14,938,018Source | 11,205,355Source | 36,564,496Source | 9,375,476Source | 5,080,221Source | 26,033,318Source | 8,888,780Source | 4,226,596Source | 12,868,473Source | 8,993,165Source | 5,189,918Source | 1,892,183Source |
| Property, Plant and Equipment, NetUSD | 413,446Source | 52,528Source | 1,901,625Source | — | 55,751Source | 1,751,234Source | — | 59,003Source | 885,520Source | 1,087Source | 53,119Source | 53,535Source |
| GoodwillUSD | 959,535Source | — | 3,035,477Source | — | — | 1,857,740Source | — | — | 977,774Source | — | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,548,664Source | 2,823,530Source | 5,993,815Source | 2,072,632Source | 2,845,066Source | 3,800,621Source | 2,072,632Source | 843,505Source | 2,892,397Source | 2,801,993Source | — | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | — | — | — | — | — | — | — | 3,984,453Source | — | — |
| Inventory, NetUSD | 128,469Source | 986,421Source | 932,508Source | — | 978,548Source | 253,558Source | — | 945,064Source | 95,098Source | — | 495,667Source | 230,145Source |
| Assets, CurrentUSD | 9,772,631Source | 8,227,826Source | 20,832,950Source | 7,302,844Source | 2,031,096Source | 16,386,587Source | 6,816,148Source | 3,140,753Source | 6,871,255Source | 6,051,001Source | 4,919,444Source | 1,551,322Source |
| Prepaid Expense and Other Assets, CurrentUSD | 770,098Source | 787,848Source | 504,599Source | 791,055Source | 923,444Source | 502,535Source | 842,199Source | 1,197,687Source | 461,239Source | 868,464Source | 1,060,765Source | 153,422Source |
| Operating Lease, Right-of-Use AssetUSD | 1,243,742Source | 101,471Source | 4,800,629Source | — | 137,535Source | 2,237,136Source | — | 172,562Source | 1,241,527Source | — | 206,582Source | 276,553Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 6,447,363Source | 2,650,133Source | 19,827,597Source | 326,301Source | 2,440,585Source | 13,426,865Source | 760,268Source | 1,740,250Source | 5,031,111Source | 2,333,601Source | 1,362,842Source | 760,873Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 74Source | 4,938Source | 615Source | 148Source | 1,889Source | 194Source | 71Source | 1,733Source | 8Source | 44Source | 1,733Source | 957Source |
| Additional Paid in CapitalUSD | 26,525,454Source | — | 45,661,728Source | 24,490,049Source | — | 38,590,321Source | 23,006,702Source | — | 28,856,496Source | — | 10,849,031Source | 3,852,044Source |
| Retained Earnings (Accumulated Deficit)USD | -18,034,757Source | -11,334,888Source | -28,926,081Source | -15,440,437Source | -9,833,631Source | -25,984,699Source | -14,878,082Source | -8,421,140Source | -21,017,440Source | -13,269,627Source | -7,023,890Source | -2,722,373Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -753Source | 228Source | — | -1,222Source | 1,242Source | — | -816Source | 1,383Source | -2,339Source | -337Source | 202Source | 111Source |
| Stockholders' Equity Attributable to ParentUSD | 8,490,655Source | 8,555,222Source | 16,736,899Source | 9,049,175Source | 2,639,636Source | 12,606,453Source | 8,128,512Source | 2,486,346Source | 7,837,362Source | 6,659,564Source | 3,827,076Source | 1,131,310Source |
| Additional Paid in Capital, Common StockUSD | — | 19,884,944Source | — | — | 12,470,136Source | — | — | 10,904,370Source | — | 19,929,484Source | — | — |
| Liabilities and EquityUSD | 14,938,018Source | 11,205,355Source | 36,564,496Source | 9,375,476Source | 5,080,221Source | 26,033,318Source | 8,888,780Source | 4,226,596Source | 12,868,473Source | 8,993,165Source | 5,189,918Source | 1,892,183Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 5,461,692Source | 2,130,422Source | 15,328,547Source | 326,301Source | 1,935,224Source | 11,297,734Source | 760,268Source | 1,222,122Source | 3,942,296Source | 1,799,134Source | 1,297,353Source | 588,272Source |
| Operating Lease, Liability, CurrentUSD | 229,229Source | 103,309Source | 647,472Source | — | 140,063Source | 493,426Source | — | 149,208Source | 247,627Source | — | 145,000Source | 110,616Source |
| Operating Lease, Liability, NoncurrentUSD | 985,671Source | — | 4,193,830Source | — | — | 1,738,911Source | — | 26,571Source | 972,843Source | — | 65,489Source | 172,601Source |
| Deferred Income Tax Liabilities, NetUSD | — | — | 30,972Source | — | — | 30,972Source | — | — | 30,972Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 30,972Source | — | — | — |
| Accounts Payable, Current | — | —Source | — | — | —Source | — | — | —Source | — | — | — | — |
| Accrued Liabilities, Current | — | —Source | — | — | —Source | — | — | —Source | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | — | —Source | —Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 8,216Source | -58,838Source | -19,160Source | 97,167Source | 487,738Source | 171,869Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | — | — | — | — | 23,218Source | 11,547Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 114,570Source | -22,966Source | -147,868Source | 403,295Source | 265,522Source | 69,328Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | — | — | — | — | 466,891Source | 65,191Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 30,972Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -2,979,595Source | -1,347,416Source | -5,933,881Source | -5,486,980Source | -4,556,811Source | -1,585,876Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | 2,019,909Source | — | 2,162,756Source | — | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -2,483,609Source | -215,319Source | -2,765,154Source | -610,564Source | -11,191Source | -32,027Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 363,087Source | — | 442,255Source | 9,160Source | — | — |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 14,412,906Source | 2,943,185Source | 10,116,738Source | 6,757,500Source | 6,738,890Source | 2,362,259Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 8,952,041Source | 1,379,981Source | 1,417,880Source | 657,602Source | 2,171,950Source | 743,043Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 7,700,562Source | 6,425,670Source | 18,141,758Source | 5,682,628Source | 14,354,374Source | 5,364,434Source | 5,402,333Source | 3,984,453Source | 3,326,851Source | 1,154,901Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 33,037Source | 789Source | 37,770Source | 69,026Source | 14,397Source | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | 2,339Source | -469Source | 177Source | -2,354Source | 1,062Source | -1,313Source |
| Additional Financial Items | ||||||||||||
| Accretion ExpenseUSD | — | — | — | — | — | — | 273,656Source | — | 130,766Source | — | — | — |
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | -58,838Source | -19,160Source | 97,167Source | 135,947Source | 47,906Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 14,568Source | — | — | — |
| DepreciationUSD | — | — | — | — | — | — | 173,904Source | 1,601Source | 96,663Source | 12,950Source | 11,649Source | 6,512Source |
| Depreciation, NonproductionUSD | — | — | — | — | — | — | — | — | — | 546Source | 10,295Source | 5,034Source |
| Financing Interest ExpenseUSD | — | — | 179,479Source | — | — | — | 561,922Source | — | 289,498Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -4,174Source | 991Source | -9,030Source | 883Source | -11,550Source | -386Source | -5,238Source | -5,846Source | -6,130Source | -2,749Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | — | — | — | — | — | — | — | 129,613Source | 129,613Source | — | — | — |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | 728,550Source | 728,550Source | — | — | — |
| Gain (Loss) on Sale of InvestmentsUSD | — | — | — | — | 63,241Source | 95,184Source | 23,151Source | -466,678Source | -113,917Source | — | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | 900Source | — | -64,245Source | 129,613Source | -32,432Source | — | — | -1,546Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | 31,261Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 726,543Source | 167,074Source | 1,605,320Source | 319,839Source | 1,381,736Source | 209,031Source | 2,238,660Source | 1,092,576Source | 2,329,067Source | 1,019,708Source |
| GoodwillUSD | — | — | 959,535Source | — | 3,035,477Source | — | 1,857,740Source | — | 977,774Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -2,616,018Source | -1,201,853Source | -2,958,972Source | -579,490Source | -4,986,760Source | -1,580,811Source | -7,780,740Source | -4,016,714Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 21,698Source | -299,404Source | 17,590Source | 17,135Source | 19,501Source | -27,644Source | 32,927Source | -2,229,023Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 30,972Source | — | — | — |
| InterestExpenseNonoperatingUSD | — | — | 17,401Source | 641,807Source | 582,241Source | 2Source | 474,170Source | 10,474Source | 257,630Source | 735,197Source | — | — |
| Investment Income, InterestUSD | — | — | 24,406Source | 95Source | 83,159Source | 36,527Source | 62,921Source | 28,856Source | 118,030Source | 12,891Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,594,320Source | -1,501,257Source | -2,941,382Source | -562,355Source | -4,967,259Source | -1,608,455Source | -7,747,813Source | -6,245,737Source | -4,301,517Source | -1,800,268Source |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | -3,766,211Source | -1,791,041Source |
| Operating ExpensesUSD | — | — | 2,276,931Source | 625,615Source | 4,212,900Source | 1,013,518Source | 3,563,648Source | 1,201,724Source | 7,067,262Source | 3,663,566Source | 4,900,791Source | 2,238,350Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | 9,446Source | — | 1,729Source | — | — | — | -535,306Source | — |
| Other Operating Income (Expense), NetUSD | — | — | — | — | — | — | — | — | — | 11,937,946Source | 4,168,622Source | 1,615,645Source |
| Payments for Repurchase of WarrantsUSD | — | — | — | — | — | — | — | 179Source | 179Source | — | — | — |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | 1,435,393Source | 430,024Source | 1,789,044Source | 139,084Source | — | — |
| Proceeds from Contributed CapitalUSD | — | — | — | — | — | — | — | — | — | — | 158,603Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | 1,484,028Source | — | 6,993,058Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | 37,500Source | 25,000Source |
| Realized Investment Gains (Losses)USD | — | — | -25,871Source | — | — | — | 23,151Source | -466,678Source | -113,917Source | — | — | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 285,948Source | — | 1,306,610Source | — | 681,994Source | — | 590,084Source | — | — | — |
| Unrealized Gain (Loss) on DerivativesUSD | — | — | — | — | — | — | — | — | — | — | -91,009Source | -74,003Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | -230,461Source | — | -32,265Source | 299,303Source | 37,587Source | -60,404Source | -216,043Source | — | — | — |
| Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | — | — | — | — | — | — | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 285,948Source | 527,478Source | 1,306,610Source | — | 681,994Source | — | 590,084Source | — | 1,712,595Source | 766,277Source |
| Cost of RevenueUSD | — | — | 207,918Source | 133,577Source | 920,919Source | — | 451,520Source | — | 404,770Source | — | 578,015Source | 318,968Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | 9,446Source | — | 1,729Source | — | — | — | -535,306Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -7,749,768Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 30,972Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,594,320Source | -1,501,257Source | -2,941,382Source | -562,355Source | -4,967,259Source | -1,608,455Source | -7,747,813Source | -6,245,737Source | -4,301,517Source | -1,800,268Source |
| Earnings Per Share, BasicUSD per share | — | — | — | -0.07Source | — | — | — | — | — | — | -0.4Source | -0.19Source |
| Earnings Per Share, DilutedUSD per share | — | — | — | -0.07Source | — | — | — | — | — | — | -0.4Source | -0.19Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 528,472Source | 4,522Source | 4,876,498Source | 14,806Source | 444,506Source | 6,485Source | 20,352Source | 79,582Source | 10,745,938Source | 9,528,863Source |
| Interest Expense (non-operating)USD | — | — | 17,401Source | 641,807Source | 582,241Source | 2Source | 474,170Source | 10,474Source | 257,630Source | 735,197Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 14,568Source | — | — | — |
| Costs and ExpensesUSD | — | — | — | — | — | — | — | — | — | — | 4,900,791Source | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 35,284Source | 136Source | 281,237Source | 20Source | 159,444Source | 1,085Source | 96,145Source | — | — | — |
| Financing Interest ExpenseUSD | — | — | 179,479Source | — | — | — | 561,922Source | — | 289,498Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -4,174Source | 991Source | -9,030Source | 883Source | -11,550Source | -386Source | -5,238Source | -5,846Source | -6,130Source | -2,749Source |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | 728,550Source | 728,550Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 726,543Source | 167,074Source | 1,605,320Source | 319,839Source | 1,381,736Source | 209,031Source | 2,238,660Source | 1,092,576Source | 2,329,067Source | 1,019,708Source |
| Gross ProfitUSD | — | — | 78,030Source | 393,901Source | 385,691Source | — | 230,474Source | — | 185,314Source | — | 1,134,580Source | 447,309Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -2,616,018Source | -1,201,853Source | -2,958,972Source | -579,490Source | -4,986,760Source | -1,580,811Source | -7,780,740Source | -4,016,714Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 8,353,923Source | — | — | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | -4.95Source | -265.78Source | -0.61Source | -39.14Source | -11.22Source | -243.76Source | -382.3Source | -50.47Source | — | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | -4.95Source | -265.78Source | -0.61Source | -39.14Source | -11.22Source | -243.76Source | -382.3Source | -50.47Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 21,698Source | -299,404Source | 17,590Source | 17,135Source | 19,501Source | -27,644Source | 32,927Source | -2,229,023Source | — | — |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 19,525Source | 2,629Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | 184,390Source | — | 103,294Source | — | — | — |
| Interest Income, OtherUSD | — | — | — | — | — | — | — | — | — | — | 5,564Source | 7,702Source |
| Investment Income, InterestUSD | — | — | 24,406Source | 95Source | 83,159Source | 36,527Source | 62,921Source | 28,856Source | 118,030Source | 12,891Source | — | — |
| Management Fee ExpenseUSD | — | — | 621,103Source | 226,104Source | 1,225,200Source | 198,345Source | 1,210,015Source | 547,557Source | 1,769,505Source | 1,367,273Source | 459,498Source | 324,395Source |
| Marketing and Advertising ExpenseUSD | — | — | 64,484Source | 11,258Source | 25,403Source | 82,329Source | 34,364Source | 35,594Source | 200,940Source | 292,522Source | 124,376Source | 36,501Source |
| Net Income (Loss) Attributable to Nonredeemable Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | 4,301,517Source | — |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | -3,766,211Source | -1,791,041Source |
| Operating ExpensesUSD | — | — | 2,276,931Source | 625,615Source | 4,212,900Source | 1,013,518Source | 3,563,648Source | 1,201,724Source | 7,067,262Source | 3,663,566Source | 4,900,791Source | 2,238,350Source |
| Other Operating Income (Expense), NetUSD | — | — | — | — | — | — | — | — | — | 11,937,946Source | 4,168,622Source | 1,615,645Source |
| Realized Investment Gains (Losses)USD | — | — | -25,871Source | — | — | — | 23,151Source | -466,678Source | -113,917Source | — | — | — |
| Research and Development ExpenseUSD | — | — | 15,000Source | 4,098Source | 310,219Source | 66,675Source | 47,061Source | 32,433Source | 147,010Source | 104,654Source | 426,243Source | 228,747Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 285,948Source | — | 1,306,610Source | — | 681,994Source | — | 590,084Source | — | — | — |
| Selling and Marketing ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 660,291Source | 192,863Source |
| Operating Income (Loss) | — | — | —Source | —Source | — | — | — | — | — | — | — | — |
| Interest Income, Debt Securities, Operating | — | — | — | — | — | — | — | —Source | — | — | — | — |
Offerings
Registration 333-290428
Registration 333-290902
Registration 333-284851
Filing attachments
ea031102401ex99-1.htm · 8-K · 2026-11-05
Exhibit 99.1 NorthStrive Biosciences Announces Results from EL-32 Preclinical Combination Study with Semaglutide and Plans for Next Phase of Development Study identifies preliminary lean-mass finding at the highest EL-32 dose while informing future preclinical development strategy Results advance NorthStrive Biosciences’ engineered probiotic platform targeting muscle preservation for patients on GLP-1 weight loss treatments NEWPORT BEACH, Calif., November 5, 2026 (GLOBE NEWSWIRE) …
Read attachment ↗ea030996901ex99-1.htm · 8-K · 2026-10-28
Exhibit 99.1 OCTOBER 2026 HOLDINGS PMGC HOLDINGS INC. DOING BUSINESS AS NORTHSTRIVE HOLDINGS INC. LEGAL DISCLAIMER Important Information for Investors This presentation (together with any accompanying oral or written communications, this "Presentation") has been prepared by PMGC Holdings Inc., doing business as NorthStrive Holdings (the "Company") solely for information purposes and does not constitute investment or legal advice. You should consult your own legal, regulatory, tax, business, fi…
Read attachment ↗ea030996901ex99-2.htm · 8-K · 2026-10-28
Exhibit 99.2 October 2026 October 2026 LEGAL DISCLAIMER Important Information for Investors This presentation (together with any accompanying oral or written communications, this "Presentation") has been prepared by PMGC Holdings Inc., doing business as NorthStrive Holdings (the "Company") on behalf of its wholly-owned subsidiary NorthStrive Defense Tech LLC, solely for information purposes and does not constitute investment or legal advice. You should consult your own legal, regulatory, tax, …
Read attachment ↗ea030585501ex99-1.htm · 8-K · 2026-09-18
EX-99.1 2 ea030585501ex99-1.htm PRESS RELEASE DATED SEPTEMBER 18, 2026 Exhibit 99.1 PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings Binding, interest-bearing payment plan converts PMGC’s 5% net sales royalty into scheduled monthly cash payments to NorthStrive Biosciences through August 2031, creating recurring, non-dilutive cash flow. ───────────────────────────────────────────…
Read attachment ↗ea030441901ex99-1.htm · 8-K · 2026-09-02
EX-99.1 4 ea030441901ex99-1.htm PRESS RELEASE DATED SEPTEMBER 1, 2026 Exhibit 99.1 NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four AI-Discovered Compounds Toward Lead Nomination in Cardiac Disease and Obesity Pursuant to a First Amendment to the Development and License Agreement, NorthStrive Biosciences and Yuva Biosciences launch a three-phase Expansion Program to advance all four AI-discovered compounds toward lead compound nominatio…
Read attachment ↗ea030362001ex99-1.htm · 8-K · 2026-08-27
EX-99.1 5 ea030362001ex99-1.htm PRESS RELEASE DATED AUGUST 25, 2026 Exhibit 99.1 PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss Proposed Mice2Space spaceflight study would evaluate EL-22 and EL-32 in mice in a real-world microgravity environment, targeting one of the most significant physiological challenges of spaceflight Three-…
Read attachment ↗